Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Beverly A. Chace"'
Publikováno v:
Clinical Pharmacology and Therapeutics. 44:158-163
The pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease were evaluated in 12 patients undergoing renal transplantation. A 12-week course beginning 24 hours before transplantation was administered in dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd75b2adee4826fa6ef78f1b261f034
https://doi.org/10.1038/clpt.1988.131
https://doi.org/10.1038/clpt.1988.131
Publikováno v:
New England Journal of Medicine. 320:1381-1387
Cytomegalovirus is a major viral pathogen in patients who undergo renal transplantation, and cytomegalovirus disease is difficult to treat. We therefore conducted a randomized, placebo-controlled, double-blind trial of acyclovir for the prevention of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4397db33cad8666f5aa20cb072f80231
https://doi.org/10.1056/nejm198905253202105
https://doi.org/10.1056/nejm198905253202105
Autor:
Beverly A. Chace, Courtney V. Fletcher, M. C. Jordan, Barbara J. Chinnock, Henry H. Balfour, Alejo Erice
Publikováno v:
Retina. 7:277
Thirty-one immunocompromised patients with severe cytomegalovirus (CMV) disease were treated with intravenous ganciclovir. Twenty-one patients had received transplants—15 bone marrow recipients, five renal allograft recipients, and one liver transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecbeefc1a173b460d297d11486159307
https://doi.org/10.1097/00006982-198707040-00013
https://doi.org/10.1097/00006982-198707040-00013